CASP8 and neoplasm: Our data suggest that at early stages of tumor growth, when p95HER2/611CTF-transformed cells start proliferating within the tumor, nutrient limitation and the likely increase in hypoxia would activate TRAIL-R/caspase-8 system and cell death.